Drug Type Small molecule drug |
Synonyms Stryka-516s |
Target |
Mechanism Integrin stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophies | Phase 2 | US | 30 Jan 2022 |